Quiddity Health has a strong track-record of helping innovative digital therapeutic companies successfully enter theUK healthcare market and reach commercial scaleBrain+ plans to have a
UK version 2.0 of CST-Therapist Companion, its new digital solution to support effective dementia therapy, ready forUK market release in Q3 2024Initially,
Quiddity Health will work with Brain+ to develop a targeted go-to-market plan for CST-Therapist Companion in theUK and build relevant pre-sale customer engagementsPost market release,
Quiddity Health will act as Brain+' full scale commercial partner under a cost-efficient revenue sharing model to reach sales acceleration in theUK healthcare marketFirst
UK sale expected late Q4 2024 with buildup of pipeline for additional sales in Q1 2025
Brain+ has entered a partnership with
Through 2023, Brain+ has developed a significantly upgraded version 2.0 of CST-Therapist Companion, its digital solution to support the delivery of Cognitive Stimulation Therapy (CST) to people with mild to moderate dementia. A
Commenting on the partnership with Brain+,
"I am extremely pleased to be able to announce our new partnership with Quiddity. Through 2023, it has become clear to us that the
Based on Quiddity experience, the expectations are to be able to close the first sale in Q4 2024 and to have a pipeline of leads for additional sales to be realized in Q1 2025.
Following commercial release, Quiddity will take the role as Brain+' full-scale commercial partner in the
Contact Information
CEO and Co-founder:
Mission: Bringing effective digitally-delivered dementia therapies to those in need, serving a million people with dementia, care-givers and clinicians by 2030
About Quiddity Health
Company website
We believe every healthcare professional should be empowered with practical solutions. Solutions best suited to their unique needs - so they can operate at their A-game, improve clinical efficiency and provide the best possible care to their patients. We also believe that digital health innovators are enabling a revolution. A revolution that will improve access to healthcare for people everywhere, regardless of wealth, ethnicity, or disability. We exist to bridge the gap and to accelerate the adoption of these solutions - identifying best fit and supporting where we can to enable better outcomes for everyone.
About Cognitive Stimulation Therapy (CST) and CST-Therapist Companion
Brain+ released a Danish pilot version of CST-Therapist Companion in late 2022 as a digital solution to support the delivery of Cognitive Stimulation Therapy (CST) to people with mild to moderate dementia. CST is an evidence based non-pharmaceutical therapy, delivered by trained CST-therapist over 14 sessions to groups of typically 4-8 people with dementia, and which has been shown to delay cognitive decline and improve both social skills and quality of life. CST is recommended by the
CST-Therapist Companion addresses these main barriers for adoption, specifically by reducing preparation time for therapists to allow more face-to-face time with patients, offering readily accessible high-quality content for the consistent delivery of CST according to the method, altogether allowing an easier and less resource intensive implementation. The goal is to facilitate that more people with dementia get access to the therapy. The quality assurance of the product instills trust in therapists as the content and methods are developed closely and with strict approval procedures with leading CST experts, including from the CST inventor
https://news.cision.com/brain--a-s/r/brain--partners-with-quiddity-health--the--1-uk-digital-healthcare-market-specialist--to-prepare-uk-,c3925611
https://mb.cision.com/Main/20893/3925611/2593796.pdf
https://news.cision.com/brain--a-s/i/1-b-en-rgb,c3265822
(c) 2024 Cision. All rights reserved., source